<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Tue, 21 Oct 2025 07:49:23 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Do the Fitness Benefits of Gastric Bypass Surgery Last?</title><link>https://www.medscape.com/viewarticle/do-fitness-benefits-gastric-bypass-surgery-last-2025a1000sih?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Although the fitness benefits of bariatric surgery wane over time, they remain evident more than a decade after the procedure. Medscape Medical News</description><pubDate>Tue, 21 Oct 2025 12:40:31 GMT</pubDate></item><item><title>Sotatercept May Benefit in Early PAH Care</title><link>https://www.medscape.com/viewarticle/sotatercept-may-benefit-early-pulmonary-arterial-2025a1000sif?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Adding sotatercept to standard therapy within a year of diagnosis lowers the risk for clinical worsening in patients with pulmonary arterial hypertens...</description><pubDate>Tue, 21 Oct 2025 12:04:02 GMT</pubDate></item><item><title>EMA Backs New Checkpoint Inhibitor for High-Risk Skin Cancer</title><link>https://www.medscape.com/viewarticle/ema-backs-new-checkpoint-inhibitor-high-risk-skin-cancer-2025a1000si7?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients with high-risk characteristi...</description><pubDate>Tue, 21 Oct 2025 11:46:38 GMT</pubDate></item><item><title>Canadaâ€™s Pharmacare Act: Still a Work in Progress</title><link>https://www.medscape.com/viewarticle/canadas-pharmacare-act-still-work-progress-2025a1000si5?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>The pharmaceutical industry and healthcare advocates are expressing concern that a single-payer pharmacare program could compromise drug access. Medsc...</description><pubDate>Tue, 21 Oct 2025 11:26:13 GMT</pubDate></item><item><title>SGLT2s Best ARNIs in Frail, Older Adults With HFpEF</title><link>https://www.medscape.com/viewarticle/sglt2-inhibitors-best-arnis-frail-older-adults-hfpef-2025a1000shi?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Real-world data reinforce SGLT2 inhibitors as first-line therapy for frail, older adults with heart failure with preserved ejection fraction. Medscape...</description><pubDate>Tue, 21 Oct 2025 03:33:01 GMT</pubDate></item></channel></rss>